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prevention as well as international guidelines. These
guidelines focus on ischemic stroke only. For the
purposes developing these guidelines, special attention
was given to studies in which Asians participated as
subjects or those which had broad international
implications for stroke care. Besides the review of current
trials, weightage was given to Cochrane reviews since
these meta analyses look at a wider spectrum of papers.
The manuscript was reviewed by several national
neurology practitioners that encounter stroke patients.
Recommendations are based on local feasibility and
relevance. Cost effectiveness and public health
implications have also influenced the strength of these
recommendations- individual patient care and
sophisticated testing is still left to the discretion of the
treating physician. These guidelines emphasize the basic
tenets of good stroke care.

Pakistan is the sixth most populous country in the world,
with an estimated population of 165 million. Non
communicable disease including stroke now accounts for
41% of the total disease burden of Pakistan. In a
population dense country like Pakistan, an estimated
4.8% may be suffering from stroke; this translates to 7.2
million individuals, compared to 700,000 annually in the
United States.
Data on the modifiable risk factors for stroke show an
alarmingly high prevalence within the population of
Pakistan. Hypertension- the single most preventable
cause of stroke- affects one in three adults aged greater
than 45 and 19% of the population aged 15 and above.
The National Health Survey of Pakistan showed that
diabetes mellitus is present in 35% of people greater
than 45 years of age. Coronary artery disease can cause
cardio-embolic stroke and is a surrogate for
atherosclerosis in the cerebrovascular system: a
population based cross sectional survey showed a
prevalence of 1 in 4 middle aged adults with men and
women at equal risk. The overall prevalence of obesity is
28 % in women and 22 % in men. The prevalence of
tobacco use is 40% in men and 12% in women.

PREHOSPITAL STROKE TRIAGE
Recognition and Triage:
In the current extended family set up with intense
population density, stroke is often recognized
immediately. However delays in presentation to care may
happen after the phase of recognition and may involve
financial constraints, lack of knowledge of therapeutic
options and inappropriate triage/delay by the primary
physician. There are several quick historical tools that
enable the effective recognition of stroke- and are
included in the detailed paper. Physicians and nurses are
encouraged to familiarize themselves with these and
utilize them to effectively triage stroke patients. In the
absence of stroke centers, these patients are best
directed to hospitals with a track record of admitting and
managing stroke patients.

Such a scenario calls for a systematic, need based and
cost-effective guideline for diagnosis, acute management
and secondary prevention of stroke which is cognizant of
the resource limitations of Pakistan. These guidelines are
a step in that direction.

PROPOSAL AND DESIGN
Methods:
The primary author (AK) reviewed all the data on current
stroke identification, management and secondary
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IN HOSPITAL MANAGEMENT OF STROKE

Establishment of stroke units:

Emergency Department:

After the patients have received acute stroke care in the
emergency department, improved clinical outcomes are
realized only when subacute stroke care is provided
through the use of focused and organized approaches
during hospitalization, including the use of stroke units.
These stroke units integrate acute and rehabilitative care
by a well-trained, multidisciplinary group including
physicians, nurses and rehabilitation personnel. The
magnitude of the benefits of stroke unit care is
comparable to that of intravenous tPA and is applicable
to the full spectrum of stroke patients.

Once on the ED bed, a rapid airway, breathing and
circulation assessment should be performed, followed
by initiation of high flow oxygen, if hypoxemic. Once
stabilized, an assessment of neurological deficits
should be performed, which would require a history and
physical examination.
If no documented piece of history is available,
information should be obtained from the time of onset
which is defined as last seen normal, brief description
of symptoms, previous similar episodes, presence of
risk factors for cerebrovascular disease, as well as any
history of drug abuse, migraine, seizure, infection,
trauma, or pregnancy This should be followed by a
physical examination. The NIHSS stroke scale score
lends itself well to a directed neurologic examination
and can quantify the degree of neurologic deficit- those
with an NIHSS stroke scale greater than 20 have a
greater chance of harboring a lesion amenable to lysis.

MANAGEMENT ISSUES AND RECOMMENDATIONS
Arterial Hypertension: An elevated arterial blood pressure
is often detected in the first hours after stroke. According
to consensus, target blood pressure in patients who are
not candidates for rt-PA should have a systolic blood
pressure of less than 220 mm Hg and a diastolic blood
pressure of less than 120 mm Hg. A blood pressure less
than these values does not warrant anti-hypertensive
medicines. In addition, the administration of sublingual
nitrates or nifedepine to precipitously lower blood
pressure is also contraindicated for any patient if he or
she presents with hypertension and focal neurological
symptoms. Those that receive intravenous rt-PA require
strict control of blood pressure to below 185/110.

The emergency department management of suspected
stroke should be prompt but comprehensive, and if
recombinant tissue plasminogen activator (rt-PA) is
available at the facility, should follow the NINDS
recommendations for stroke chain of survival: 10
minutes for the emergency physician evaluation,
specialist (neurologist) assessment within 10 minutes,
and 25 minutes to CT scan, allowing rt-PA
administration within 45 minutes to an hour.

Thrombolysis: The current FDA approved treatment for
acute stroke presenting within 3 hours of symptom onset
is intravenous recombinant tissue type plasminogen
activator (rt-PA). This recommendation in based on the
observed outcomes of the NINDS trial, performed in
1996, which assessed early and late neurological
outcomes in a group of patients treated with rt-PA once a
hemorrhage was ruled-out on a CT scan. In this trial there
was a relative risk reduction of 33% at 3 months and a
symptomatic ICH rate of 6.8%. The dose of rt-PA was
0.9 mg/kg. A lower dose of 0.6 mg/kg has been used
successfully in a Japanese trial and requires testing in
Asian populations.

Imaging of the brain is recommended in some form
before initiating stroke specific therapy. An emergency
non contrast head CT accurately identifies most cases
of intracranial hemorrhage and helps discriminate non
vascular causes of acute neurologic symptoms e.g.
brain tumour. The CT is also adequate pretesting for rtPA prior to infusion and shows certain important
prognostic signs. Although multimodal MRI are
available in certain centers they are expensive and add
little to the clinical management of stroke patients in
this region if no neurointerventional therapy is planned
or offered.

Temperature: Increased body temperature in the setting
of acute stroke is associated with poor neurologic
outcomes. Although trials testing acute hypothermia as a
neuroprotective therapy in stroke are underway, it seems
prudent to avoid hyperthermia and treat temperature
elevations aggressively after stroke. Common reasons are
aspiration pneumonia, IV line phlebitis and urinary tract
infection, these may worsen outcomes therefore

Ancillary testing at the very least should consider a 12
lead EKG, Blood tests for diabetes, abnormal lipids and
coagulations, screen for chronic renal failure. Carotid
testing should be offered if intervention is accepted by
the family.
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aggressive search for the source of infection and early
institution of antibiotics is suggested. Avoid the
cannulation of a paralyzed extremity to reduce the
chances of iatrogenic infections.

swallowing capacity. A patient with stroke should be
screened for the presence of swallowing problems with the
water swallowing tests and modifications in the diet
should be made accordingly. Aspiration is the major risk
factor for pneumonia after stroke. Patients who fail the
initial swallowing screen should get a nasogastric tube
placed for medications and feeds. Those who are having
difficulty handling even their basic secretions, may actually
benefit from nil per oral policy in the initial 24 hours.

Hyperglycemia: Hyperglycemia has detrimental outcomes
after stroke. It increases the chances of hemorrhagic
conversion. Persistent hyperglycemia at the rate of >
200 mg / dl independently predicts stroke expansion. A
reasonable approach is to initiate treatment to reduce
blood glucose when the glucose level exceeds 200
mg/dL, the desired level of glucose should be between
80- 140 mg / dl. It is encouraged to have glucometers in
hospital units and train staff to manage insulin infusions
in a systematized manner.

Prevention of bed sores: All patients unable to mobilize
independently are at risk of developing pressure sores.
They should ideally be provided with a pressure relieving
mattress as an alternative to a standard hospital mattress.
Also there should be standing instructions for repositioning these patients every two hours to avoid
pressure sores.

Anticoagulation: The early administration of either dose
adjusted IV heparin or a low molecular weight heparin is
associated with an increased risk of bleeding
(intracerebral and extra-cranial) complications. These
medications increase the risk of symptomatic
hemorrhagic transformation in those with severe stroke.
Urgent anticoagulation with the goal of preventing early
recurrent stroke, halting worsening, or improving
outcomes after ischemic stroke is not recommended.
This is regardless of etiology of stroke e.g. cardio embolic
stroke. Anticoagulation is contraindicated within 24 hours
of administration of rt-PA.

Deep vein thrombosis: Avoidance of deep vein thrombosis
in immobilized patients via frequent movements and the
use of low dose s/c heparin is suggested in the acute
phase. Intermittent compression devices are
recommended in those where the risk of ICH is high.
Early Rehabilitation: Patients with stroke should be
mobilized rapidly. There is very frequently a delay and this
would avoid significant complications.
Steroids: Contrary to the popular practice, steroids do not
appear to have any beneficial role in management of
patients with presumed acute stroke. According to the last
Cochrane database systematic review of seven trials in
2002, treatment with corticosteroids did not appear to
show any improvement in functional outcomes of stroke
survivors. Furthermore, usage of steroids in these cases
may elicit unwanted adverse effects such as
hyperglycemia and infections.

Antiplatelet Agents: Antiplatelet therapy with aspirin 160
to 325 mg daily, given orally (or per rectum in patients
who cannot swallow), and started within 48 hours of
onset of presumed ischemic stroke reduces the risk of
early recurrent ischemic stroke without a major risk of
early hemorrhagic complications and improves long-term
outcome. The acute administration of clopidrogel,
ticlopidine or any other alternate antiplatelet agent has
not been tested in acute stroke. Large trials such as
International Stroke Trial (IST) and Chinese Acute Stroke
Trial (CAST) have proved the benefits of long term daily
aspirin in prevention of major vascular events post stroke,
with the latter being exclusively an Asian study, and
hence complementing our population better.

Neuroprotection and Neurotonics: No single trial has
shown convincing benefit of stroke neuroprotection and
efficacy of intervention is doubtful. At the same time, the
widespread practice of administration of these agents
remains in vogue in Pakistan. These must be stopped
because of the economic toll on patients and their
families are not justified.

Nutrition and Hydration: Patients should receive isotonic
hydration and free fluids should be avoided. Nutritional
supplementation is not necessary. However an evaluation
for aspiration is needed prior to initiation of diet and the
diet should be modified accordingly.

POST HOSPITAL STROKE MANAGEMENT
All stroke survivors are at a high risk of stroke recurrence,
by mechanisms which may be dependent on the
pathophysiology of the primary stroke. The following
discussion focuses on measures that are globally
beneficial.

Aspiration: A wet gurgling voice after stroke, a marked
facial weakness, marked cognitive slowing or inattention
suggest the need to screen for silent aspiration. The
presence of a gag reflex doesn't equate with an organized
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Antithrombotic therapy: In general any antiplatelet agent
initiated after stroke has an odds ratio of 28% in the
reduction of nonfatal stroke and a 16% reduction in fatal
stroke. Aspirin in a dose ranging from 75 to 300 mg is
efficacious in stroke prevention. There is no evidence
that increasing the dose of aspirin provides additional
benefit in those patients who have a stroke while on
aspirin. The higher dose ranges are associated with a
greater risk of gastrointestinal hemorrhage. Clopidogrel is
marginally better at increased cost and is therefore
suggested in those with concomitant peripheral vascular
disease and / or intolerance to aspirin. The combination
of aspirin and dipyridamole may offer additional
protection. However there are concerns in patients with
angina (a frequent co-morbid) and this combination
must be avoided in those patients. Combination therapy
in stroke patients with aspirin and clopidogrel has
reported higher risks of symptomatic ICH. The use of
these agents in combination for TIA is not known, with
early reports suggesting benefit. Dose adjusted warfarin
is suggested in an INR 2-3 for those who have
intermittent or continous atrial fibrillation. Cilostazol is
another inhibitor of platelet aggregation that works by
inhibiting the cellular phosphodiesterase. However, at
present there is insufficient evidence to support its use
for all stroke patients.

studies for Asian population are warranted nonetheless
where the population attributable risk of hypertension as
a cause of stroke may be very high. It should however,
be emphasized that the goal is to reduce blood pressure
and any anti hypertensive which will ensure compliance
in the long run will be preferable. Therefore the drug
should be selected depending on the availability and the
financial status of the patient.
Lipid Control: Unlike coronary heart disease, association
of dyslipidemias with stroke occurrence as well as
recurrence is weak. However, recent trials have shown
the benefits of using statins for prevention of stroke in
those with Coronary artery disease. Simvastatin and
Pravastatin were the drugs used in these trials. This
effect may not hold true for patients with cerebrovascular
disease, where despite significant reduction in incidence
of coronary events, the reduction in incidence of
recurrent strokes was not significant, as concluded by
the Heart Protection Study (HPS).
In contradistinction, Stroke Prevention by Aggressive
Reduction of Cholesterol Levels (SPARCL) study has
shown that Atorvastatin 80 mg/day significantly reduced
the risk of stroke in patients who previously had a stroke
or transient ischemic attack (TIA) and who had no known
cardiovascular disease. The proposed underlying
mechanisms by which statins reduce this incidence are
poorly understood, but it is widely believed that the
results are more dramatic than simple fall of cholesterol
levels might suggest. Therefore, statins may have a
multifactorial effect in prevention against cerebrovascular
diseases. It appears that statins may reduce the risk of
stroke in those with previous stroke or TIA and therefore
these may be considered an independent atherosclerotic
equivalent for the initiation of statins in selected
patients.

Blood Pressure Control: The association between both
systolic and diastolic blood pressures (BPs) and the risk
of ischemic stroke is continuous. As compared to
compelling evidence of role of blood pressure control for
primary prevention of stroke, data on secondary
prevention is lacking. It is known that a mean blood
pressure fall of 5 mm Hg leads to a one third reduction
of stroke. This association should hold true, if not
stronger, for individuals who have had a cerebrovascular
event before. Effective blood pressure control as defined
by The Joint National Committee on Prevention,
Detection, Evaluation, and Treatment of High Blood
Pressure (JNC 7) would be the management of choice
for stroke patients. This would mean a target blood
pressure control of <120 systolic and <80 diastolic,
along with lifestyle changes and dietary modification.
This target would be irrespective of co-morbids.

Therefore, patients with ischemic stroke or TIA with
elevated cholesterol, comorbid coronary artery disease,
or evidence of an atherosclerotic origin should be
counseled regarding lifestyle modification, dietary
guidelines, and medication recommendations Statin
agents are recommended, and the target goal for
cholesterol lowering for those with CHD or symptomatic
atherosclerotic disease is an LDL-C of <100 mg/dL and
LDL-C of <70 mg/dL for very-high-risk persons with
multiple risk factors.

The only large trial assessing efficacy of
antihypertensives for secondary prevention of stroke was
the PROGRESS trial, looking at the outcomes of patients
receiving an ACE-I (perindopril) with a diuretic
(indapamide). This combination led to a 43% reduction
in recurrence of stroke. It appears that for at least 70%
of patients with hypertension >160/90 mmHg, a two
drug regimen would be necessary. Recommending these
two classes of antihypertensives based on evidence
appears to be a safe option; randomized controlled
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Diabetes mellitus: Diabetes being a factor associated with
primary stroke is well known, but there is insufficient data
to support its role in recurrence. The recommendations
for glucose control, hence, should be the same for
patients with and without a prior stroke.

and 88 cm (35 in) in women, was shown to be an
independent risk factor for ischemic stroke in the
Northern Manhattan Stroke Study. Optimum cut-offs for
abdominal obesity for South Asian population have been
proposed by Misra et al comparing waist circumference
(WC) to standardized Asia-Pacific BMI cut-offs and
equating cardiovascular risk factors. Even though no
consensus exists in principle accepting or rejecting this
proposal, it should be understood that South Asian
population has far severe implications for each unit of
weight gained compared to the western populations,
hence calling for a more aggressive dietary control.

Control of other modifiable cardiovascular risk factors in a
patient with diabetes is one of the most essential and
challenging issues. Aggressive blood pressure control in
these patients is critical for decrease in recurrence.
Furthermore, aggressive lipid control is also warranted for
such patients. All classes of anti-hypertensives are
approved for use in diabetes, though it is largely agreed
that more than one agent should be used, and also that
one of the agents should either be an ACE-I or ARB. This
recommendation holds for patients with cardiovascular as
well as cerebrovascular events.

Exercise - regular physical activity: This has an indirect
effect on stroke prevention through lowering of blood
pressure. A meta-analysis by Whelton et al. in which the
experience of 1,108 normotensive persons enrolled in 27
randomized controlled trials was included, identified a
4.04 mmHg (95 percent CI, 2.75-5.32) reduction in
systolic blood pressure in those assigned to aerobic
exercise compared with the control group. The magnitude
of the intervention effect appears to be independent of
the intensity of the exercise program. It is recommended
that persons exercise for at least 30 minutes on most, if
not all, days of the week.

Smoking: Smoking has been repeatedly identified as a
significant risk factor for the occurrence of ischemic
stroke. The most important Asian study assessing
relationship between smoking and incidence of stroke in
this population was one of the arms of Japan Public
Health Centre -based prospective study on cancer and
cardiovascular diseases (JPHC Study) cohort 1. This
looked at almost 40,000 Japanese middle aged men and
women followed up over a period of 12 years to see
development of strokes, and confirmed a positive
relationship between smoking and risk of total stroke and
subarachnoid hemorrhage after adjustment for known
cardiovascular risk factors and selected lifestyles.
In the presence of such convincing evidence against the
use of tobacco, physicians should ask their patients
repeatedly to quit smoking for both primary and
secondary prevention.

Dietary salt restriction: This again has impact on stroke
risk indirectly through its impact on lowering blood
pressure. At least three meta-analysis of the efficacy of
reduced sodium intake in lowering blood pressure have
been published since 1993. In all three reports, sodium
reduction was associated with a small but significant
reduction in systolic blood pressure in normotensive
persons. In the NHANES I Epidemiologic Follow-up Study,
He et al. reported that a 100 mmol higher level of
sodium intake in overweight persons was associated with
a 32 percent increase in stroke incidence, a 89 percent
increase in stroke mortality, a 44 percent increase in
CHD mortality, a 61 percent increase in CVD mortality,
and a 39 percent increase in mortality from all causes.
These data support the premise that a lower intake of
dietary sodium reduces the risk of subsequent CVD.

A detailed smoke cessation guide is available at the NIH
smoking cessation website. This guide is a good
reference for patients to ease the difficulties they face
while
attempting
to
quit.
(http://www.smokefree.gov/pubs/clearing_the_air.pd).
Nicotine products and oral medications have been shown
to be useful in helping patients quit smoking.

Depression: The prevalence of depression in Pakistan has
been estimated to be as high as 34%. Stroke survivors
are at a greater risk of developing depression, and this
affects their recovery from stroke. Data from a local
hospital revealed prevalence of post-stroke depression to
be 37.9 % using DSM IV criteria among 174 patients
presenting to the outpatient clinics, with most patients
presenting within three months of the primary stroke.
Early identification and management of depression post
stroke is vital to ensure early recovery, and preventing
cognitive impairment. Conventional tricyclic
antidepressants are contra-indicated among stroke
patients due to their adverse effects. SSRIs have a low

Obesity: The prevalence of obesity in Pakistan is
determined to be as high as 23% among urban males
and 40% among urban females, while rural areas report
lower prevalence. This was based on Body Mass Index,
BMI calculation using the Asia-pacific criteria. [BMI is the
most widely used measurement for obesity which
approximates body mass using a mathematical ratio of
weight and height [(weight in kg ÷ height in meters2)].
However, it is now believed that abdominal obesity, rather
than generalized obesity, has a stronger association with
cardiovascular morbidity. Abdominal obesity, defined by a
waist circumference more than 102 cm (40 in) in men
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adverse effect profile and a good efficacy, making them
invaluable in patients with multiple co-morbidities.

FUTURE DIRECTIONS AND NEED
Pragmatic Population based interventional risk reduction
programs are needed to reduce the burden of stroke in
vulnerable populations.
Research into the known and emerging risk factors for
stroke is required to enhance the cost effectiveness and
relevance of these interventions.
(Detailed version of these guidelines including references
could be downloaded from Pakistan Society of Neurology
web site: www.pakneurology.net )
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